搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium cellulolyticum Thiamine-phosphate synthase (thiE) CSB-YP488848DUL
CSB-EP488848DUL
CSB-BP488848DUL
CSB-MP488848DUL
CSB-EP488848DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Transcriptional repressor NrdR (nrdR) CSB-YP488849DUL
CSB-EP488849DUL
CSB-BP488849DUL
CSB-MP488849DUL
CSB-EP488849DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP488850DUL
CSB-EP488850DUL
CSB-BP488850DUL
CSB-MP488850DUL
CSB-EP488850DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum UPF0042 nucleotide-binding protein Ccel_2290 (Ccel_2290) CSB-YP488851DUL
CSB-EP488851DUL
CSB-BP488851DUL
CSB-MP488851DUL
CSB-EP488851DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum ATP synthase gamma chain (atpG) CSB-YP488852DUL
CSB-EP488852DUL
CSB-BP488852DUL
CSB-MP488852DUL
CSB-EP488852DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum 30S ribosomal protein S12 (rpsL) CSB-YP488853DUL
CSB-EP488853DUL
CSB-BP488853DUL
CSB-MP488853DUL
CSB-EP488853DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum ATP phosphoribosyltransferase regulatory subunit (hisZ) CSB-YP488854DUL
CSB-EP488854DUL
CSB-BP488854DUL
CSB-MP488854DUL
CSB-EP488854DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP488855DUL
CSB-EP488855DUL
CSB-BP488855DUL
CSB-MP488855DUL
CSB-EP488855DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Maf-like protein Ccel_2565 (Ccel_2565) CSB-YP488856DUL
CSB-EP488856DUL
CSB-BP488856DUL
CSB-MP488856DUL
CSB-EP488856DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Aspartate carbamoyltransferase (pyrB) CSB-YP488857DUL
CSB-EP488857DUL
CSB-BP488857DUL
CSB-MP488857DUL
CSB-EP488857DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Ribonuclease HII (rnhB) CSB-YP488858DUL
CSB-EP488858DUL
CSB-BP488858DUL
CSB-MP488858DUL
CSB-EP488858DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum 30S ribosomal protein S14 type Z (rpsZ) CSB-YP488859DUL
CSB-EP488859DUL
CSB-BP488859DUL
CSB-MP488859DUL
CSB-EP488859DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum DNA-directed RNA polymerase subunit alpha (rpoA) CSB-YP488860DUL
CSB-EP488860DUL
CSB-BP488860DUL
CSB-MP488860DUL
CSB-EP488860DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium cellulolyticum Trigger factor (tig) CSB-YP488861DUL
CSB-EP488861DUL
CSB-BP488861DUL
CSB-MP488861DUL
CSB-EP488861DUL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium nodulans Tyrosine recombinase XerC (xerC) CSB-YP488862MTB
CSB-EP488862MTB
CSB-BP488862MTB
CSB-MP488862MTB
CSB-EP488862MTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium nodulans 30S ribosomal protein S4 (rpsD) CSB-YP488863MTB
CSB-EP488863MTB
CSB-BP488863MTB
CSB-MP488863MTB
CSB-EP488863MTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium nodulans Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP488864MTB
CSB-EP488864MTB
CSB-BP488864MTB
CSB-MP488864MTB
CSB-EP488864MTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium nodulans Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP488865MTB
CSB-EP488865MTB
CSB-BP488865MTB
CSB-MP488865MTB
CSB-EP488865MTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium nodulans Ribosome-binding factor A (rbfA) CSB-YP488866MTB
CSB-EP488866MTB
CSB-BP488866MTB
CSB-MP488866MTB
CSB-EP488866MTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium nodulans 50S ribosomal protein L21 (rplU) CSB-YP488867MTB
CSB-EP488867MTB
CSB-BP488867MTB
CSB-MP488867MTB
CSB-EP488867MTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>